Casein Kinase II, antagonists & inhibitors
- Name
- Casein Kinase II, antagonists & inhibitors
- Accession Number
- DBCAT004652
- Description
Not Available
- Drugs
Drug Drug Description Silmitasertib Silmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery). - Drugs & Drug Targets
Drug Target Type